CIHR Industry Partnered Programs - February 2006 Competition Results
(Rx&D, SME and Industry Partnered Strategic Initiatives)
CIHR/Rx&D Collaborative Research Program
A total of eight (8) applications were submitted to the CIHR/Rx&D Collaborative Research Program. Two (2) applications were approved for funding (success rate of 25%).
| CIHR/Rx&D Collaborative Research Program | Applications Received | Applications Approved for Funding |
| CIHR/Rx&D Operating Grants |
5 |
0 |
| CIHR/Rx&D Research Chairs [ HTML | PDF (83 KB) | Help ] |
1 |
1 |
| CIHR/Rx&D Fellowships |
1 |
0 |
| CIHR/Rx&D New Investigator |
1 |
1 |
CIHR/Small and Medium Enterprise (SME) Research Program
A total of nine (9) applications were submitted to the CIHR/SME Research Program. Five (5) applications were approved for funding (success rate of 56%).
| CIHR/SME Research Program | Applications Received | Applications Approved for Funding |
| CIHR/SME Operating Grants |
7 |
3 |
| CIHR/SME Fellowships |
2 |
2 |
Industry Partnered Strategic Initiatives
A total of three (3) Industry-partnered strategic initiatives were adjudicated in the competition. Results of these initiatives can be found in the table below.
| Strategic Initiatives | Partner(s) | Applications Received | Applications Approved for Funding |
| Fellowship Awards - Wyeth Pharmaceuticals Partnered [ HTML | PDF (83 KB) | Help ] |
Wyeth |
2 |
1 |
| CIHR/Canadian Association for Medical Oncologists (CAMO) Rx&D Fellowship [ HTML | PDF (84 KB) | Help ] |
GSK, Ortho Biotech, Eli Lilly, Pfizer, CAMO |
3 |
3 |
| CIHR/Canadian Association for the Study of the Liver (CASL) Rx&D Fellowship | Astellas Pharma, Axcan Pharma, Schering, Hoffmann-La Roche and Ortho-biotech |
6 |
5 |
